Patients who were positive for cytomegalovirus had more immune cells circulating in their blood before they started ...

The first CAR-T cell therapy was developed and approved by the FDA in 2017 to treat relapsed or refractory B-cell precursor ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

As ubiquitous as lab testing is in healthcare, health plans still often overlook its importance to healthcare quality and ...

Capricor officials said the company was prepared for the meeting and does not expect it to delay the FDA’s decision on the ...